On March 7th, Shenzhen Dashicheng Optical Technology Co., Ltd. (referred to as “Shenzhen Dashicheng”), a provider of contact lens supply chain solutions, recently completed a tens of millions yuan Series A+ financing round, led by Shenzhen Capital Group Co., LTD. This round of financing will be used to accelerate the expansion of the contact lens production line, research and development of new products and materials, and the layout of the global compliant market. Previously, the company had received a tens of millions yuan Series A2 financing from Capital Nuts.
Regarding this financing, Li Jiayi, the founder of Shenzhen Dashicheng, said, “We hope to lower the entry barrier for brand owners through professional and compliant one-stop flexible supply chain services for contact lenses, allowing more standardized and high-quality contact lens products to enter the global market.”
In addition, Dr. Tian Li from Shenzhen Capital Group Co., LTD.’s Hotland Innovation Asset Management stated, “China’s contact lens production has long been constrained by supply chain bottlenecks and urgently needs to achieve independent and controllable high-quality supply chain alternatives. As the only contact lens production company in mainland China with FDA registration, Dashicheng has been widely recognized by numerous contact lens brands at home and abroad, and its products are selling well globally.”
Public information shows that Shenzhen Dashicheng is a Sino-Korean joint venture contact lens supply chain company and a medical device company specializing in contact lens research and production. According to Shenzhen Dashicheng’s official website, it possesses world-leading third-generation contact lens production technology and ranks among the top three in global production capacity. Its main customers include top global brands such as Bausch + Lomb, O-lens, and Candy Magic.
